Prevalence of heart failure in Australia: a systematic review

Berhe W Sahle, Alice J Owen, Mutsa P Mutowo, Henry Krum, Christopher M Reid, Berhe W Sahle, Alice J Owen, Mutsa P Mutowo, Henry Krum, Christopher M Reid

Abstract

Background: In the absence of a systematic collection of data pertaining to heart failure, summarizing the data available from individual studies provides an opportunity to estimate the burden of heart failure. The present study systematically reviewed the literature to estimate the incidence and prevalence rates of heart failure in Australia.

Methods: Studies reporting on prevalence or incidence of heart failure published between 1990 and 2015 were identified through a systematic search of Embase, PubMed, Ovid Medline, MeSH, Scopus and websites of the Australian Institute of Health, and Welfare and Australian Bureau of Statistics.

Results: The search yielded a total of 4978 records, of which thirteen met the inclusion criteria. There were no studies reporting on the incidence of heart failure. The prevalence of heart failure in the Australian population ranged between 1.0% and 2.0%, with a significant proportion of cases being previously undiagnosed. The burden of heart failure was higher among Indigenous than non-Indigenous Australians (age-standardized prevalence rate ratio of 1.7). Heart failure was prevalent in women than men, and in rural and remote regions than in the metropolitan and capital territories.

Conclusion: This systematic review highlights the limited available data on the epidemiology of heart failure in Australia. Population level studies, using standardized approaches, are needed in order to precisely describe the burden of HF in the population.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram of selection process

References

    1. Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, et al. Heart failure: preventing disease and death worldwide. ESC Heart Failure. 2014;1:425.
    1. McMurray JJV, Stewart S. The burden of heart failure. Eur Heart J Supplements. 2002;4:D50–D58. doi: 10.1016/S1520-765X(02)90160-4.
    1. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. Eur Heart J. 2004;25:1614–1619. doi: 10.1016/j.ehj.2004.06.038.
    1. Hobbs FD, Roalfe AK, Davis RC, Davies MK, Hare R, Midlands Research Practices Consortium (MidReC) Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES) Eur. Heart J. 2007;28:1128–34. doi: 10.1093/eurheartj/ehm102.
    1. Willcox S. Chronic diseases in Australia: the case for changing course. Background and policy paper No. 02/2014. Melbourne, Mitchell Institute. Available at: [Cited 28 September 2015].
    1. Reid CM. Cardiovascular diseases in Australia: calm before a new storm? Clin. Exp. Pharmacol. Physiol. 2013;40(6):345–346. doi: 10.1111/1440-1681.12093.
    1. Australian Institute of Health and Welfare . Cardiovascular, diabetes and chronic kidney disease series no. 2. Cat. no. CDK 2. Canberra: AIHW; 2014. Cardiovascular disease, diabetes and chronic kidney disease— Australian facts: Prevalence and incidence.
    1. Waters A-M, Trinh L, Chau T, Bourchier M, Moon L. Latest statistics on cardiovascular disease in Australia. Clin. Exp. Pharmacol. Physiol. 2013;40:347–56. doi: 10.1111/1440-1681.12079.
    1. Woods JA, Katzenellenbogen JM, Davidson PM, Thompson SC. Heart failure among indigenous Australians: a systematic review. BMC Cardiovasc Disord. 2012;12:99. doi: 10.1186/1471-2261-12-99.
    1. Snyder ML, Love SA, Sorlie PD, Rosamond WD, Antini C, Metcalf PA, et al. Redistribution of heart failure as the cause of death: the Atherosclerosis Risk in Communities Study. Popul Health Metr. 2014;12:10. doi: 10.1186/1478-7954-12-10.
    1. Inglis SC, Clark RA, Shakib S, Wong DT, Molaee P, Wilkinson D, et al. Hot summers and heart failure: seasonal variations in morbidity and mortality in Australian heart failure patients (1994–2005) Eur J Heart Fail. 2008;10:540–549. doi: 10.1016/j.ejheart.2008.03.008.
    1. Moher D, Liberati A, Tetzlaff J, Altman D, The PRISMA Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(6):e1000097. doi: 10.1371/journal.pmed.1000097.
    1. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 2007;36:666–76. doi: 10.1093/ije/dym018.
    1. Australian Bureau of Statistics, National Health Survey: Summary of results 2004–05. Cat. no. 4364.0.Canberra:ABS;2006.
    1. Australian Bureau of Statistics, National Health Survey: Summary of Results, 2007–2008 (Reissue). Cat. no. 43640DO020_20072008. Canberra: ABS;2009.
    1. Australian Bureau of Statistics, National Health Survey: First Results, 2011–12. Cat. no. 43640DO003_20112012. Canberra: ABS; 2012.
    1. Knox SA, Harrison CM, Britt HC, Henderson J. Estimating prevalence of common chronic morbidities in Australia. Med J Aust. 2008;189:66–70.
    1. Harrison C, Britt H, Miller G, Henderson J. Prevalence of chronic conditions in Australia. PloS One. 2013;8:e67494. doi: 10.1371/journal.pone.0067494.
    1. Abhayaratna WP, Smith WT, Becker NG, Marwick TH, Jeffery IM, McGill DA. Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study. Med J Aust. 2006;184:151–4.
    1. Clark RA, Eckert KA, Stewart S, Phillips SM, Yallop JJ, Tonkin AM, et al. Rural and urban differentials in primary care management of chronic heart failure: new data from the CASE study. Med J Aust. 2007;186:441–445.
    1. McGrady M, Krum H, Carrington MJ, Stewart S, Zeitz C, Lee GA, et al. Heart failure, ventricular dysfunction and risk factor prevalence in Australian aboriginal peoples: the Heart of the Heart Study. Heart. 2012;98(21):1562–1567. doi: 10.1136/heartjnl-2012-302229.
    1. AIHW. Penm E. Cardiovascular disease series no. 29. Cat. no. CVD 41. Canberra: Australian Institute of Health and Welfare; 2008. Cardiovascular disease and its associated risk factors in Aboriginal and Torres Strait Islander peoples 2004–05.
    1. Clark RA, Driscoll A, Nottage J, McLenan S, Coombie DM, Bamford EJ, et al. Inequitable provision of optimal services for patients with chronic heart failure: a national geo-mapping study. Med J Aust. 2007;186:169e73.
    1. AIHW: Field B . Heart failure…what of the future? Bulletin no. 6. AIHW Cat. No. AUS 34. Canberra: AIHW; 2003.
    1. Clark RA, McLennan S, Eckert K, Dawson A, Wilkinson D, Stewart S. Chronic heart failure beyond city limits. Rural Remote Health. 2005;5:443.
    1. Clark RA, McLennan S, Dawson A, Wilkinson D, Stewart S. Uncovering a hidden epidemic: a study of the current burden of heart failure in Australia. Heart Lung Circ. 2004;13:266–73. doi: 10.1016/j.hlc.2004.06.007.
    1. Quach S, Blais C, Quan H. Administrative data have high variation in validity for recording heart failure. Can J Cardiol. 2010;26(8):306–312. doi: 10.1016/S0828-282X(10)70438-4.
    1. Zarrinkoub R, Wettermark B, Wändell P, Mejhert M, Szulkin R, Ljunggren G, et al. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail. 2013;15(9):995–1002. doi: 10.1093/eurjhf/hft064.
    1. Valle R, Baccichetto R, Barro S, Calderan A, Carbonieri E, Chinellato M, et al. Heart failure in Eastern Veneto: prevalence, hospitalization rate, adherence to guidelines and social costs. Monaldi Arch Chest Dis. 2006;66(1):63–74.
    1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8:30–41. doi: 10.1038/nrcardio.2010.165.
    1. Bhatnagar P, Williams J, Townsend N. The epidemiology of cardiovascular disease in the United Kingdom 2014. Heart 2015 doi:10.1136/heartjnl- 2015–307516
    1. Mehta PA, Cowie MR. Gender and heart failure: a population perspective. Heart. 2006;92(suppl 3):iii14–iii18.
    1. Patten RD. Models of gender differences in cardiovascular disease. Drug Discov Today Dis Models. 2007;4(4):227–232. doi: 10.1016/j.ddmod.2007.11.002.
    1. Nichols M, Peterson K, Herbert J, Allender S. Australian heart disease statistics. Overweight, obesity and cardiovascular disease – past, present and future. Melbourne: National Heart Foundation of Australia;2015.
    1. Meredith PA, Ostergren J. From hypertension to heart failure – are there better primary prevention strategies? J Renin Angiotensin Aldosterone Syst. 2006;7:64–73. doi: 10.3317/jraas.2006.012.
    1. Lenzen MJ, Rosengren A, OP Reimer WJMS, Follath F, Boersma E, Simoons ML, et al. Management of patients with heart failure in clinical practice: differences between men and women. Heart. 2008;94:e10. doi: 10.1136/hrt.2006.099523.
    1. Adams KF, Jr, Zannad F, France N. Clinical definition and epidemiology of advanced heart failure. Am Heart J. 1998;135:S-204–S-215. doi: 10.1016/S0002-8703(98)70251-0.
    1. Krum H, Abraham WT. Heart failure. Lancet. 2009;373:941–55. doi: 10.1016/S0140-6736(09)60236-1.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다